Clarity Asset Management »

Sarepta Therapeutics shares owned by Clarity Asset Management

Quarter-by-quarter ownership of Sarepta Therapeutics (SRPT) shares owned by Clarity Asset Management from 13F filings

Historical chart of Clarity Asset Management investment in Sarepta Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics held by Clarity Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics by Clarity Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $3.1k 25 124.88
2024-06-30 $4.0k 25 158.00
2024-03-31 $3.2k 25 129.48
2023-12-31 $2.4k 25 96.44

More positions owned by Clarity Asset Management

American Centy Etf Tr Avantis Respon U (AVSU)
Vanguard World Esg Us Stk Etf (ESGV)
American Centy Etf Tr Avantis Responsi (AVSD)
Nushares Etf Tr Nuveen Esg Lrgcp (NULG)
Ishares Tr Esg Awr Msci Usa (ESGU)
Ishares Tr National Mun Etf (MUB)
Pimco Etf Tr Muni Income Opp (MINO)
Nushares Etf Tr Nuveen Esg Lrgvl (NULV)
Ishares Msci Emrg Chn (EMXC)
Ishares U S Etf Tr Blackrock Short (MEAR)
Pimco Etf Tr Enhancd Short (EMNT)
J P Morgan Exchange Traded F Ultra Sht Muncpl (JMST)
Ishares Tr Esg Adv Ttl Usd (EUSB)
Ishares Tr S&p 500 Grwt Etf (IVW)
Ishares Tr Core S&p Ttl Stk (ITOT)

View all positions for Clarity Asset Management

Top funds holding Sarepta Therapeutics

BlackRock
BlackRock
Vanguard Group
Capital Research and Management Company - Division 3
State Street Corporation
Henderson Group
Morgan Stanley
Farallon Capital Management
Jpmorgan Chase & Co
Bank of New York Mellon
T. Rowe Price Investment Management
Geode Capital Management
Deutsche Bank Aktiengesellschaft
EcoR1 Capital
Citadel Advisors

View all funds holding Sarepta Therapeutics